372 related articles for article (PubMed ID: 15669026)
1. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
Petroianu GA; Arafat K; Schmitt A; Hasan MY
J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
[TBL] [Abstract][Full Text] [Related]
2. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
[TBL] [Abstract][Full Text] [Related]
3. In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox).
Petroianu G; Arafat K; Kosanovic M; Saleh A; Camasamudram V; Hasan MY
J Appl Toxicol; 2003; 23(6):447-51. PubMed ID: 14635269
[TBL] [Abstract][Full Text] [Related]
4. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon.
Petroianu G; Kühn F; Thyes C; Ewald V; Missler A
J Appl Toxicol; 2003; 23(1):75-9. PubMed ID: 12518340
[TBL] [Abstract][Full Text] [Related]
5. Weak inhibitors protect cholinesterases from stronger inhibitors (dichlorvos): in vitro effect of tiapride.
Petroianu GA; Schmitt A; Arafat K; Hasan MY
Int J Toxicol; 2005; 24(2):79-86. PubMed ID: 16036766
[TBL] [Abstract][Full Text] [Related]
6. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by mipafox.
Petroianu G; Kühn F; Arafat K; Zuleger K; Missler A
J Appl Toxicol; 2004; 24(2):143-6. PubMed ID: 15052610
[TBL] [Abstract][Full Text] [Related]
7. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
8. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
9. Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sha Ullah M; Naseer O
J Appl Toxicol; 2005; 25(1):68-73. PubMed ID: 15669039
[TBL] [Abstract][Full Text] [Related]
10. Metoclopramide protection of cholinesterase from paraoxon inhibition.
Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
[TBL] [Abstract][Full Text] [Related]
11. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
[TBL] [Abstract][Full Text] [Related]
12. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
[TBL] [Abstract][Full Text] [Related]
13. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
15. Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro.
Bartling A; Thiermann H; Szinicz L; Worek F
J Appl Toxicol; 2005; 25(6):568-71. PubMed ID: 16167316
[TBL] [Abstract][Full Text] [Related]
16. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
Musilova L; Kuca K; Jung YS; Jun D
Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
[TBL] [Abstract][Full Text] [Related]
17. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
[TBL] [Abstract][Full Text] [Related]
18. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
19. Comparative sensitivity of bovine and rodent acetylcholinesterase to in vitro inhibition by organophosphate insecticides.
Cohen SD; Williams RA; Killinger JM; Freudenthal RI
Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):452-9. PubMed ID: 2417385
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cholinesterases by histamine 2 receptor antagonist drugs.
Laine-Cessac P; Turcant A; Premel-Cabic A; Boyer J; Allain P
Res Commun Chem Pathol Pharmacol; 1993 Feb; 79(2):185-93. PubMed ID: 8095733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
